436 related articles for article (PubMed ID: 29614676)
21. Distinct 18F-AV-1451 tau PET retention patterns in early- and late-onset Alzheimer's disease.
Schöll M; Ossenkoppele R; Strandberg O; Palmqvist S; ; Jögi J; Ohlsson T; Smith R; Hansson O
Brain; 2017 Sep; 140(9):2286-2294. PubMed ID: 29050382
[TBL] [Abstract][Full Text] [Related]
22. Widespread brain tau and its association with ageing, Braak stage and Alzheimer's dementia.
Lowe VJ; Wiste HJ; Senjem ML; Weigand SD; Therneau TM; Boeve BF; Josephs KA; Fang P; Pandey MK; Murray ME; Kantarci K; Jones DT; Vemuri P; Graff-Radford J; Schwarz CG; Machulda MM; Mielke MM; Roberts RO; Knopman DS; Petersen RC; Jack CR
Brain; 2018 Jan; 141(1):271-287. PubMed ID: 29228201
[TBL] [Abstract][Full Text] [Related]
23. Cross-sectional associations between [
Teng E; Ward M; Manser PT; Sanabria-Bohorquez S; Ray RD; Wildsmith KR; Baker S; Kerchner GA; Weimer RM
Neurobiol Aging; 2019 Sep; 81():138-145. PubMed ID: 31280117
[TBL] [Abstract][Full Text] [Related]
24. [
Whitwell JL; Lowe VJ; Tosakulwong N; Weigand SD; Senjem ML; Schwarz CG; Spychalla AJ; Petersen RC; Jack CR; Josephs KA
Mov Disord; 2017 Jan; 32(1):124-133. PubMed ID: 27787958
[TBL] [Abstract][Full Text] [Related]
25. Subtypes of progressive aphasia: application of the International Consensus Criteria and validation using β-amyloid imaging.
Leyton CE; Villemagne VL; Savage S; Pike KE; Ballard KJ; Piguet O; Burrell JR; Rowe CC; Hodges JR
Brain; 2011 Oct; 134(Pt 10):3030-43. PubMed ID: 21908392
[TBL] [Abstract][Full Text] [Related]
26. Inferior temporal tau is associated with accelerated prospective cortical thinning in clinically normal older adults.
Scott MR; Hampton OL; Buckley RF; Chhatwal JP; Hanseeuw BJ; Jacobs HI; Properzi MJ; Sanchez JS; Johnson KA; Sperling RA; Schultz AP
Neuroimage; 2020 Oct; 220():116991. PubMed ID: 32512123
[TBL] [Abstract][Full Text] [Related]
27. Longitudinal neuroimaging biomarkers differ across Alzheimer's disease phenotypes.
Sintini I; Graff-Radford J; Senjem ML; Schwarz CG; Machulda MM; Martin PR; Jones DT; Boeve BF; Knopman DS; Kantarci K; Petersen RC; Jack CR; Lowe VJ; Josephs KA; Whitwell JL
Brain; 2020 Jul; 143(7):2281-2294. PubMed ID: 32572464
[TBL] [Abstract][Full Text] [Related]
28. The role of age on tau PET uptake and gray matter atrophy in atypical Alzheimer's disease.
Whitwell JL; Martin P; Graff-Radford J; Machulda MM; Senjem ML; Schwarz CG; Weigand SD; Spychalla AJ; Drubach DA; Jack CR; Lowe VJ; Josephs KA
Alzheimers Dement; 2019 May; 15(5):675-685. PubMed ID: 30853465
[TBL] [Abstract][Full Text] [Related]
29. Elevated occipital β-amyloid deposition is associated with widespread cognitive impairment in logopenic progressive aphasia.
Whitwell JL; Lowe VJ; Duffy JR; Strand EA; Machulda MM; Kantarci K; Wille SM; Senjem ML; Murphy MC; Gunter JL; Jack CR; Josephs KA
J Neurol Neurosurg Psychiatry; 2013 Dec; 84(12):1357-64. PubMed ID: 23946416
[TBL] [Abstract][Full Text] [Related]
30. 18F-AV-1451 tau PET imaging correlates strongly with tau neuropathology in MAPT mutation carriers.
Smith R; Puschmann A; Schöll M; Ohlsson T; van Swieten J; Honer M; Englund E; Hansson O
Brain; 2016 Sep; 139(Pt 9):2372-9. PubMed ID: 27357347
[TBL] [Abstract][Full Text] [Related]
31. Diverging patterns of amyloid deposition and hypometabolism in clinical variants of probable Alzheimer's disease.
Lehmann M; Ghosh PM; Madison C; Laforce R; Corbetta-Rastelli C; Weiner MW; Greicius MD; Seeley WW; Gorno-Tempini ML; Rosen HJ; Miller BL; Jagust WJ; Rabinovici GD
Brain; 2013 Mar; 136(Pt 3):844-58. PubMed ID: 23358601
[TBL] [Abstract][Full Text] [Related]
32. Longitudinal rates of atrophy and tau accumulation differ between the visual and language variants of atypical Alzheimer's disease.
Sintini I; Graff-Radford J; Schwarz CG; Machulda MM; Singh NA; Carlos AF; Senjem ML; Jr CRJ; Lowe VJ; Josephs KA; Whitwell JL
Alzheimers Dement; 2023 Oct; 19(10):4396-4406. PubMed ID: 37485642
[TBL] [Abstract][Full Text] [Related]
33. In vivo Patterns of Tau Pathology, Amyloid-β Burden, and Neuronal Dysfunction in Clinical Variants of Alzheimer's Disease.
Dronse J; Fliessbach K; Bischof GN; von Reutern B; Faber J; Hammes J; Kuhnert G; Neumaier B; Onur OA; Kukolja J; van Eimeren T; Jessen F; Fink GR; Klockgether T; Drzezga A
J Alzheimers Dis; 2017; 55(2):465-471. PubMed ID: 27802224
[TBL] [Abstract][Full Text] [Related]
34. Tau PET in Alzheimer disease and mild cognitive impairment.
Cho H; Choi JY; Hwang MS; Lee JH; Kim YJ; Lee HM; Lyoo CH; Ryu YH; Lee MS
Neurology; 2016 Jul; 87(4):375-83. PubMed ID: 27358341
[TBL] [Abstract][Full Text] [Related]
35. Microbleeds in atypical presentations of Alzheimer's disease: a comparison to dementia of the Alzheimer's type.
Whitwell JL; Kantarci K; Weigand SD; Lundt ES; Gunter JL; Duffy JR; Strand EA; Machulda MM; Spychalla AJ; Drubach DA; Petersen RC; Lowe VJ; Jack CR; Josephs KA
J Alzheimers Dis; 2015; 45(4):1109-17. PubMed ID: 25649655
[TBL] [Abstract][Full Text] [Related]
36. The Imaging Features and Clinical Associations of a Novel Tau PET Tracer-18F-APN1607 in Alzheimer Disease.
Hsu JL; Lin KJ; Hsiao IT; Huang KL; Liu CH; Wu HC; Weng YC; Huang CY; Chang CC; Yen TC; Higuchi M; Jang MK; Huang CC
Clin Nucl Med; 2020 Oct; 45(10):747-756. PubMed ID: 32701794
[TBL] [Abstract][Full Text] [Related]
37. Brain metabolic correlates of CSF Tau protein in a large cohort of Alzheimer's disease patients: A CSF and FDG PET study.
Chiaravalloti A; Barbagallo G; Ricci M; Martorana A; Ursini F; Sannino P; Karalis G; Schillaci O
Brain Res; 2018 Jan; 1678():116-122. PubMed ID: 29066367
[TBL] [Abstract][Full Text] [Related]
38. A multicentre longitudinal study of flortaucipir (18F) in normal ageing, mild cognitive impairment and Alzheimer's disease dementia.
Pontecorvo MJ; Devous MD; Kennedy I; Navitsky M; Lu M; Galante N; Salloway S; Doraiswamy PM; Southekal S; Arora AK; McGeehan A; Lim NC; Xiong H; Truocchio SP; Joshi AD; Shcherbinin S; Teske B; Fleisher AS; Mintun MA
Brain; 2019 Jun; 142(6):1723-1735. PubMed ID: 31009046
[TBL] [Abstract][Full Text] [Related]
39. Kinetic Modeling of the Tau PET Tracer
Barret O; Alagille D; Sanabria S; Comley RA; Weimer RM; Borroni E; Mintun M; Seneca N; Papin C; Morley T; Marek K; Seibyl JP; Tamagnan GD; Jennings D
J Nucl Med; 2017 Jul; 58(7):1124-1131. PubMed ID: 27908967
[No Abstract] [Full Text] [Related]
40. Correlation of In Vivo [18F]Flortaucipir With Postmortem Alzheimer Disease Tau Pathology.
Smith R; Wibom M; Pawlik D; Englund E; Hansson O
JAMA Neurol; 2019 Mar; 76(3):310-317. PubMed ID: 30508025
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
